Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-099733)

Filing Details

Accession Number:: 0001104659-21-099733
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-04 06:05:34
Reporting Period:: 2021-08-03

Accepted Time:: 2021-08-04 06:05:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1790340	Immuneering Corp	IMRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1870437	Matthew Brett Hall	C/O Immuneering Corporation, 245 Main Street, Second Floor Cambridge MA 02142	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-08-03	5,040	$0.00	5,040	No	4	C	Direct
Class A Common Stock	Acquisiton	2021-08-03	1,353	$15.00	6,393	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Series A Preferred Stock	Disposition	2021-08-03	1,636	$0.00	1,636	$0.00
Class A Common Stock	Series B Preferred Stock	Disposition	2021-08-03	3,404	$0.00	3,404	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.